Clinical Trial Update: Caduet and TLC Intervention in Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Caduet with a TLC lifestyle intervention in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED